November 2014 FDA Recall Drug by Zydus Pharmaceuticals Usa Inc
D-0299-2015 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Zydus Pharmaceuticals Usa Inc on November 26, 2014 for the product Drug. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0299-2015

Reason for Recall
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Initiated
11-26-2014
Reported
12-24-2014
Quantity
58,920 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Zydus Pharmaceuticals USA Inc
Nationwide and Puerto Rico
Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.

Batch or Lot Expiration Information

Lot# : MP2137, MP2138, MP2139, Exp 01/16; MP3614, Exp 03/16; MP5611, MP5613, Exp 05/16